155 related articles for article (PubMed ID: 3348605)
1. In vitro activities of LY163892, cefaclor, and cefuroxime.
Knapp CC; Washington JA
Antimicrob Agents Chemother; 1988 Jan; 32(1):131-3. PubMed ID: 3348605
[TBL] [Abstract][Full Text] [Related]
2. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
Dubreuil L; Derriennic M; Sedallian A
Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity and beta-lactamase stability of LY163892.
Pelosi E; Fontana R
Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):549-51. PubMed ID: 3141170
[TBL] [Abstract][Full Text] [Related]
4. Comparative in-vitro activity of a new oral carbacephem, LY163892.
Howard AJ; Dunkin KT
J Antimicrob Chemother; 1988 Oct; 22(4):445-56. PubMed ID: 3060458
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
Shelton MM; Welch DF
Chemotherapy; 1989; 35(2):88-94. PubMed ID: 2788068
[TBL] [Abstract][Full Text] [Related]
6. Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins.
Jorgensen JH; Redding JS; Maher LA
Antimicrob Agents Chemother; 1988 Oct; 32(10):1477-80. PubMed ID: 3190179
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic activity of five oral cephalosporins against Haemophilus influenzae.
Stein GE; Schooley S; Walker RD; Strenkoski-Nix L
Pharmacotherapy; 1997; 17(2):235-41. PubMed ID: 9085313
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
Jones RN; Barry AL
J Antimicrob Chemother; 1988 Sep; 22(3):315-20. PubMed ID: 3182429
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity and beta-lactamase stability of LY163892.
Cao C; Chin NX; Neu HC
J Antimicrob Chemother; 1988 Aug; 22(2):155-65. PubMed ID: 3263352
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae.
Powell M; Williams JD
J Antimicrob Chemother; 1988 Jan; 21(1):27-31. PubMed ID: 3258594
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of BMY-28100, a new oral cephalosporin.
Eliopoulos GM; Reiszner E; Wennersten C; Moellering RC
Antimicrob Agents Chemother; 1987 Apr; 31(4):653-6. PubMed ID: 3496846
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibilities of common pediatric pathogens to LY163892.
Shelton S; Nelson JD
Antimicrob Agents Chemother; 1988 Feb; 32(2):268-70. PubMed ID: 3129989
[TBL] [Abstract][Full Text] [Related]
14. Reassessment of cefaclor breakpoints for Haemophilus influenzae.
MacKenzie FM; Milne KE; Gould IM
J Chemother; 2004 Aug; 16(4):329-33. PubMed ID: 15332705
[TBL] [Abstract][Full Text] [Related]
15. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
Braveny I; Dickert H; Machka K
Infection; 1979; 7(5):231-6. PubMed ID: 389804
[TBL] [Abstract][Full Text] [Related]
16. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
Bauernfeind A
Diagn Microbiol Infect Dis; 1991; 14(1):63-74. PubMed ID: 2013211
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
Simon C
Infection; 1987; 15(2):122-4. PubMed ID: 3596808
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Delmée M; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
Acta Clin Belg; 1996; 51(4):237-43. PubMed ID: 8858889
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
Tomatsu K; Ando S; Masuyoshi S; Kondo S; Hirano M; Miyaki T; Kawaguchi H
J Antibiot (Tokyo); 1987 Aug; 40(8):1175-83. PubMed ID: 3500158
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of cefaclor (author's transl)].
Knothe H
Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
